Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoprotein(a)”

352 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 352 results

Post-approval studies (Phase 4)Study completedNCT00006190
What this trial is testing

Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT05565742
What this trial is testing

LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 320
Not applicableStudy completedNCT02770872
What this trial is testing

The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk

Who this might be right for
Cardiovascular Disease
Lisa Tannock 19
Large-scale testing (Phase 3)Study completedNCT00654602
What this trial is testing

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Who this might be right for
Dyslipidaemia
AstraZeneca 1,500
Early research (Phase 1)Study completedNCT02314442
What this trial is testing

An Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Hypercholesterolemia
Alnylam Pharmaceuticals 70
Testing effectiveness (Phase 2)Study completedNCT04270760
What this trial is testing

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Who this might be right for
Cardiovascular Disease
Amgen 281
Large-scale testing (Phase 3)Study completedNCT02658175
What this trial is testing

The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome

Who this might be right for
Familial Chylomicronemia SyndromeLipoprotein Lipase DeficiencyHyperlipoproteinemia Type 1
Akcea Therapeutics 68
Not applicableStudy completedNCT03887520
What this trial is testing

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 49,001
Large-scale testing (Phase 3)Study completedNCT00092638
What this trial is testing

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 450
Large-scale testing (Phase 3)Active Not RecruitingNCT04023552
What this trial is testing

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 8,323
Large-scale testing (Phase 3)Active Not RecruitingNCT05900141
What this trial is testing

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Who this might be right for
Hyperlipoproteinemia (a)
Novartis Pharmaceuticals 41
Not applicableUnknownNCT03152656
What this trial is testing

A Registration Study for Familial Hypercholesterolemia in Taiwan

Who this might be right for
Familial Hypercholesterolemia
National Taiwan University Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT02633956
What this trial is testing

Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)

Who this might be right for
Nonalcoholic Steatohepatitis
Intercept Pharmaceuticals 84
Not applicableUnknownNCT05323227
What this trial is testing

Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

Who this might be right for
Coronary Artery Disease
Shanghai Zhongshan Hospital 378
Testing effectiveness (Phase 2)Study completedNCT00689442
What this trial is testing

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Who this might be right for
Dyslipidemia
Akros Pharma Inc. 105
Post-approval studies (Phase 4)UnknownNCT02579499
What this trial is testing

Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Diseasse
Yonsei University 4,400
Not applicableUnknownNCT05330819
What this trial is testing

Thrombogenicity of Lipoprotein A: Laboratory Study Defining the Prothrombotic Effects of Lipoprotein A

Who this might be right for
Cardiovascular Disease and Lipid DisordersCardiac Disease
South Tees Hospitals NHS Foundation Trust 20
Large-scale testing (Phase 3)Looking for participantsNCT06597006
What this trial is testing

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia - Homozygous
Novartis Pharmaceuticals 9
Very early researchStudy completedNCT02650726
What this trial is testing

Purified Anthocyanins Supplementation and High-Density Lipoprotein (HDL) Function

Who this might be right for
Diabetes Mellitus，Type 2
Sun Yat-sen University 80
Testing effectiveness (Phase 2)Study completedNCT01426438
What this trial is testing

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 99
Load More Results